Your Trusted Source for Biopharma News

Editorial

View All
Your Trusted Source for Biopharma News
Editorial Biopharma's 2026 Playbook: AI, M&A, and the Race for Pipeline Security

The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…

MindWalk and Teva Team Up to Advance AI Antibody Discovery
EditorialMindWalk and Teva Team Up to Advance AI Antibody Discovery

Over the past few years, applying AI to drug discovery has become a crowded, well-funded field. In

Regenerative Medicine and Rare Disease Therapy Innovations
EditorialRegenerative Medicine and Rare Disease Therapy Innovations

The move from research-level discovery to established clinical use is a critical juncture that

Seven Biopharma Trends to Watch in 2026
EditorialSeven Biopharma Trends to Watch in 2026

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

From Breakthroughs to Scale: Biopharma Platforms Shaping 2026
EditorialFrom Breakthroughs to Scale: Biopharma Platforms Shaping 2026

In 2026, boards and customers are asking a direct question: can promising science be turned into

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Boltz Raises $110 Million to Scale Molecular Intelligence
Tech & Innovation Boltz Raises $110 Million to Scale Molecular Intelligence

The emergence of "agentic" scientific exploration allows AI agents to autonomously set up computational jobs and iterate on complex hypotheses for days to solve intricate molecular design challenges. This paradigm shift is at the heart of Boltz, a Massachusetts Institute of Technology spinoff that

Supercomputing Framework Predicts Protein Interactions via Evolution
Tech & InnovationSupercomputing Framework Predicts Protein Interactions via Evolution

The transition from the original 2008 model to the current framework was made possible by the

PC-Based Control Drives Innovation in Personalized Medicine
Tech & InnovationPC-Based Control Drives Innovation in Personalized Medicine

Transitioning to a software-defined laboratory model allows researchers to change scientific

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later